Surging oil prices and a new wave of US trade investigations are creating a double shock for global markets, forcing investors to reassess risks around energy supply, inflation and global trade.
Risk-off sentiment dragged the ASX healthcare sector lower this week, headlined by Immutep’s plunge after scrapping a Phase III trial even as Pro Medicus secured fresh contract wins.
